A total of 21 patients with myasthenia underwent thymectomy with removal of hyperplastic thymus tissue. Thymectomy in 14 patients was performed using a thoracoscopic approach and in seven via thoracotomy. Serum anti-acetylcholine receptor levels were assayed after surgery and demonstrated increases in both groups of patients in the early post-operative period (one month) as compared with the pre-operative period. It is suggested that these changes represent the immune response to the stress situation associated with surgical intervention. The increase in antibody levels was somewhat greater in patients with thoracotomy access, which may be associated with the greater volume of tissue removed.
Similar content being viewed by others
References
P. S. Vetshev, A. G. Sanadze, D. V. Sidnev, et al., “Antibodies to titin in patients with myasthenic and nonmyasthenic thymoma,” Khirurgiya, 6, 53–56 (2007).
M. I. Kuzin, and B. M. Gekht, Myasthenia [in Russian], Meditsina, Moscow (1996).
A. G. Sanadze, B. M. Gekht, D. V. Sidnev, et al., “Antibodies to acetylcholine receptors in the diagnosis of myasthenia and other forms associated with pathology of neuromuscular transmission,” Nevrol. Zh., 8, No. 1, 19–20 (2003).
D. V. Sidnev, M. Yu. Karganov, N. I. Shcherbakova, et al., “Antibodies to acetylcholine receptors in patients with different clinical forms of myasthenia and Lambert–Eaton myasthenic syndrome,” Zh. Nevrol. Psikhiat., 106, No. 1, 53–55 (2006).
D. V. Sidnev, A. G. Sanadze, N. I. Shcherbakova, and A. V. Kondrat’ev, “Antibodies to titin in assessing the efficacy of thymectomy in patients with generalized myasthenia without thymoma,” Grud. Serd.-Sosud. Khir., No. 4, 48–50 (2007).
D. V. Sidnev, A. G. Sanadze, S. I. Dedaev, et al., “Antibodies to acetylcholine receptors in assessing the efficacy of the pathogenetic treatment of patients with myasthenia,” Zh. Nevrol. Psikhiat., No. 12, 74–77 (2010).
D. F. Skripnichenko and M. M. Shevnyuk, The Diagnosis and Treatment of Myasthenia [in Russian], Zdorov’ya, Kiev (1991).
V. P. Kharchenko, D. S. Sarkisov, P. S. Vetshev, et al., Thymus Diseases [in Russian], Triada-X, Moscow (1998).
A. P. Kalinin, N. A. Maistrenko, and P. S. Vetshev (eds.), Surgical Endocrinology [in Russian], Piter, Moscow, St. Petersburg (2004), pp. 404–462.
A. Blalock, “Tumors of the thymic region and myasthenia gravis,” Am. J. Surg., 57, 149–150 (1941).
B. M. Conti-Fine, M. Milani, and H. J. Kaminski, “Myasthenia gravis: past, present and future,” J. Clin. Invest., 116, No. 11, 2843–2854 (2006).
P. C. Dau, J. M. Lindsrom, C. K. Cassel, et al., “Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis,” J. Neurol. Sci., 29, No. 5, 734–738 (1993).
D. Drachman, R. Adams, L. Josifek, and S. Self, “Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis,” New Eng. J. Med., 307, 769–773 (1982).
G. S. Gronseth and R. J. Barohn, “Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology,” Neurology, 55, 7–15 (2000).
R. Hohlfeld, A. Melms, C. Schneider, et al., “Therapy of myasthenia gravis and myasthenic syndromes,” in: Neurological Disorders: Course and Treatment, T. Brandt et al. (eds.), Elsevier, Amsterdam (2003), pp. 1341–1362.
A. Jaretzki 3rd, R. Barohn, R. M. Ernstoff, et al., “Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America,” Neurology, 55, 16–23 (2000).
K. Kagotani, Y. Monden, K. Nakahara, et al., “Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis,” J. Thorac. Cardiovasc. Surg., 90, No. 1, 7–12 (1985).
G. Keanes, “The results of thymectomy in myasthenia gravis,” Brit. Med. J., No. 2, 611–616 (1949).
J. C. Keesey, “Clinical evaluation and management of myasthenia gravis,” Muscle Nerve, 29, No. 4, 484–505 (2004).
S. G. Khicha, L. R. Kaiser, and J. B. Sharger, “Extended transcervical thymectomy in the treatment of myasthenia gravis,” Ann. N.Y. Acad. Sci., 1132, 336–343 (2008).
J. B. Kuks, H. J. Oosterhuis, P. C. Limburg, and T. H. The, “Antiacetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis,” Clin. Correlation J. Autoimmun., 4, No. 2, 197–211 (1991).
J. Lindstrom and E. H. Lambert, “Content of acetylcholine receptor and antibodies bound to receptor to myasthenia gravis, experimental autoimmune myasthenia gravis and Eaton–Lambert syndrome,” Neurology, 28, 130–138 (1978).
J. Newsom-Davis, G. Cutter, G. Wolfe, et al., “Status of the thymectomy trial for nonthymomatous myasthenia gravis. Patients receiving prednisone,” Ann. N.Y. Acad. Sci., 1132, 344–347 (2008).
H. J. Oosterhuis, P. C. Limburg, E. Hummel-Tapell, et al., “Antiacetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy,” J. Neurol. Sci., 69, No. 3, 335–343 (1985).
P. M. Pego Fernandez, J. R. Milanez de Campos, J. Biscegli, et al., “Thymectomy by partial sternotomy for the treatment of myasthenia gravis,” Ann. Thorac. Surg., 74, 203–208 (2002).
J. C. Ruckert, M. Ismail, M. Swierz, et al., “Thoracoscopic thymectomy with the Da Vinci Robotic System for myasthenia gravis,” Ann. N.Y. Acad. Sci., 1132, 329–335 (2008).
F. Schumm, A. Fateh-Moghadam, and J. Dichgans, “Correlation of acetylcholine receptor antibodies and clinical severity of myasthenia gravis in combined immunosuppressive therapy,” Eur. Arch. Psychiat. Neurol. Sci., 234, No. 4, 224–230 (1984).
N. Shibuya, T. Sato, M. Osame, et al., “Immunoadsorption therapy for myasthenia gravis,” J. Neurol. Neurosurg. Psychiat., 57, No. 5, 578–581 (1994).
J. R. Sonett and A. Jaretzki III, “Thymectomy for nonthymomatous myasthenia gravis: A critical analysis,” Ann. N.Y. Acad. Sci., 1132, 315–328 (2008).
A. Vincent, J. Newsom-Davis, P. Newton, and N. Beck, “Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis,” Neurology, 33, No. 10, 1276–1282 (1983).
A. Vincent, P. J. Whiting, M. Schluep, et al., “Antibody heterogeneity and specificity in myasthenia gravis,” Ann. N.Y. Acad. Sci., 505, 106–120 (1987).
R. Voltz, R. Hohlfeld, A. Faten-Moghadam, et al., “Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671,” Neurology, 41, 1836–1838 (1991).
G. I. Wolfe, H. J. Kaminski, A. Jaretzki, et al., “Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy,” Ann. N.Y. Acad. Sci., 998, 473–480 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 112, No. 9, Iss. I, pp. 32–36, September, 2012.
Rights and permissions
About this article
Cite this article
Nikishov, V.N., Bogdanov, E.I., Sanadze, A.G. et al. Thymectomy and Antibodies to Acetylcholine Receptors in Myasthenia Patients during the Early Post-Operative Period. Neurosci Behav Physi 43, 1121–1125 (2013). https://doi.org/10.1007/s11055-013-9859-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-013-9859-0